Crane NXT, Co. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Crane NXT, Co. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2,748	2,786	3,346	3,075	2,937	3,408	3,375	1,391	1,487	1,657
Cost of revenue	1,758	1,771	2,156	1,942	1,931	746	714	737	822	953
Gross profit	990	1,015	1,189	1,179	965	1,241	2,661	654	665	704
Research and development	61.5	58.5	89.1	74	74.6	33.2	33.9	42.8	39.5	46
Selling, general and administrative	611	606	712	679	698	323	319	367	386	440
Operating expenses	2,561	2,398	2,904
Operating income	187	388	441	183	263	279	301	287	269	247
Interest expense	36.5	36.1	50.9	46.8	55.3	46.9	52.2
Interest income	1.9	2.5	2.3	2.7	2	0.1	0.2	1.1	1.6	1
Other non-operating income	-22.6	-20.9	-29.9	-39.2	-38.4	-53.1	-53	-47	-42.4	-65.7
Pre-tax income	164	368	411	144	225	226	248	240	226	181
Income tax	40.3	195	75.9	31.3	43.4	48.1	43.4	51.5	42.3	35.9
Income from continuing operations	123	172	336	112	163	394
Net income to minority interests	1	0.7	-0.1	0.3	0.1	0	0	0	0	0
Net income	123	172	336	133	181	178	205	188	184	145
EBITDA	254	461	561	291	390	361	380	364	356	353
EPS, basic	0.90	1.23	2.40	0.95	1.32	3.14	3.61	3.31	3.22	2.53
EPS, diluted	0.88	1.21	2.35	0.94	1.31	3.14	3.61	3.28	3.19	2.50
Shares, basic (weighted)	137	139	140	140	137	56.7	56.7	56.8	57.1	57.4
Shares, diluted (weighted)	139	142	143	142	138	56.7	56.7	57.5	57.8	58
Dividend per share		0.56	0.60	0.67	0.73	1.72	1.88	0.42	0.64	0.68

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	510	706	343	394	551	479	231	227	166	234
Receivables	396	418	516	555	424	483	205	215	266	352
Inventory	343	349	412	457	430	449	146	157	145	170
Other current assets	19.5	19.6	76.2	79.5	137	119	41.9	45.2	57.4	85.1
Total current assets	1,316	1,519	1,363	1,500	1,574	1,543	623	644	643	853
Property, plant and equipment	279	282	599	616	574	556	262	261	272	304
Lease right-of-use assets				113	104	96.8	34	47.8	60.4	67.2
Goodwill	1,207	1,207	1,404	1,301	1,609	861	837	841	957	1,164
Intangible assets	282	277	478	505	433	389	345	309	419	557
Other non-current assets	95	115	101	211	197	259	56.7	71	92.3	96.6
Total assets	3,428	3,594	4,043	4,424	4,615	4,487	2,129	2,129	2,387	3,116
Accounts payable	223	247	329	311	199	274	110	107	117	132
Accrued liabilities	223	252	337	378	388	443	204	211	211	186
Deferred revenue		27	50.8	88.4	103	101	93.6	92.5	71.4	87.3
Short-term debt	0	249	6.9	0	376	0	300	4.6	210	135
Total current liabilities	521	838	740	917	1,057	789	631	334	562	569
Long-term debt	745	494	942	842	843	842	544
Lease liabilities				91.5	86.4	79.4	29	42.6	52.7	55.6
Other non-current liabilities	99.8	108	84.6	188	171	161	38.5	63.7	80.2	116
Total liabilities	2,282	2,245	2,516	2,947	3,084	2,652	1,346	1,165	1,322	1,860
Total debt	745	494	949	842	843	842	545	640	541	1,004
Paid-in capital	277	292	304	316	331	364	0	1,728	1,720	1,717
Retained earnings	1,720	1,813	2,072	2,112	2,193	2,527	0	121	268	375
Treasury stock	-459	-452	-476	-543	-601	-691	-864	-839	-823	-811
Other comprehensive income	-476	-380	-448	-484	-466	-440	-132	-119	-173	-99.9
Shareholders' equity	1,134	1,345	1,524	1,474	914	764	784	964	1,065	1,253
Minority interests	11.9	3.3	2.9	2.6	2.2	2.8	2.6		0	-3.1
Total equity	1,146	1,349	1,527	1,476	1,531	1,835	784	964	1,065	1,250
Total liabilities and equity	3,428	3,594	4,043	4,424	4,615	4,487	2,129	2,129	2,387	3,116
Shares outstanding	138	139	139	138	136	57.8	56.3	56.9	57.2	57.4

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	124	173	336	134	181	435	401	188	184	145
Depreciation and amortization	67.4	72.7	120	108	128	81.8	78.7	77.6	86.8	107
Stock-based compensation	21.7	21.8	21.6	21.8	22.3	8.6	9.3	10.3	10.6	12.7
Deferred income tax	-25.1	102	47.7	-28.3	18.1	8.2	-28.4	-2.1	-14.9	-14.5
Change in receivables	-6.2	-10.1	4.8	1.9	139	-22.2	0.3	-6.3	-44.4	-46.8
Change in inventory	24.9	6.4	-38.8	-8.8	35.4	9.3	-12.7	-1	21.3	5.2
Change in payables	5.5	17.5	37	-13.6	-103	21.9	13.9	-6.8	5.7	5.9
Cash from operations	318	318	414	394	310	277	306	276	214	242
Capital expenditures	-51.5	-49	-109	-64.4	-34.1	-18.6	-21.3	-31.1	-45.4	-43.2
Acquisitions	0	-54.8	-648	-156	-170	0	0	0	-270	-391
Purchases of investments			0	-8.8	-90	-10	0	0	0	-117
Sales and maturities of investments			0	9.9	60	40	0
Cash from investing	-50.6	-86.7	-752	-221	-229	-15.8	-21.3	-31.1	-318	-549
Debt issued	0	0	567	3	0	0	0	350	0	532
Debt repaid	0	0	-452	-99.4	0	0	0	-300	0	0
Stock issued	26.4	25.2	16.1	11.4	8.9	0	0	5	3.3	2.6
Share buybacks	0	-25	-50.1	-79.9	-70	-96.3	-204
Dividends paid	-77.2	-78.4	-83.5	-93.2	-100	0	0	-23.7	-36.6	-39
Cash from financing	-100	-80.8	-7.9	-125	55.1	-298	-135	-253	62.1	364
Exchange rate effect	-20.9	46.5	-16.4	2.2	21.6	-7	-20.2	3.8	-12	16.7
Net change in cash	146	197	-363	50.5	157	-43.9	130	-3.5	-53.8	72.8
Free cash flow	267	269	305	330	275	258	285	245	169	198
Interest paid	36.8	36	47.5	47.4	53.8	41.2	41.2	45.1	44.1	55.6
Income taxes paid	69.8	84.1	58.4	35.1	46.5	25.3	63.5	46	63.8	50.9

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $47.72 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	42.1%	Gross profit / revenue.
Operating margin	14.0%	Operating income / revenue.
EBITDA margin	21.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	9.8%	Pre-tax income / revenue.
Net margin	7.8%	Net income / revenue.
Operating cash flow margin	15.0%	Cash from operations / revenue.
Effective tax rate	20.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	11.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.9%	Net income / average total assets.
Return on invested capital (ROIC)	8.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	27.2%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.4%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	7.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	11.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-21.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-10.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	5.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-35.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-6.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-8.2%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-6.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-1.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-0.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-2.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-2.0%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-21.2%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-10.9%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-4.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-21.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-11.5%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	13.7%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	12.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-7.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-4.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	17.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-11.4%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-6.4%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	6.3%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	-28.8%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	-1.5%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	17.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	16.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	6.5%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	30.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	13.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-7.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-15.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.42x	Current assets / current liabilities.
Quick ratio	0.92x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.33x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.00x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	35.0%	Total debt / total assets.
Liabilities / assets	64.2%	Total liabilities / total assets.
Net debt	$1.03B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.71x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$287.7M	Current assets - current liabilities.
Goodwill and intangibles / assets	60.7%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$915.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.50x	Revenue / average total assets.
Fixed asset turnover	5.66x	Revenue / average property, plant and equipment.
Inventory turnover	4.38x	Cost of revenue / average inventory.
Days inventory	83 days	365 x average inventory / cost of revenue.
Receivables turnover	4.43x	Revenue / average receivables.
Days sales outstanding	82 days	365 x average receivables / revenue.
Days payables	42 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	124 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.42	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$31.08	Revenue / diluted weighted shares.
Operating cash flow per share	$4.66	Cash from operations / diluted weighted shares.
Book value per share	$22.00	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$15.90	Tangible book value / shares outstanding.
Cash per share	$4.02	(Cash + short-term investments) / shares outstanding.
Payout ratio	28.7%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$2.75B	Share price x shares outstanding.
Enterprise value	$3.78B	Market cap + total debt - cash - short-term investments.
P/E	19.6x	Market cap / net income. Only when net income is positive.
P/S	1.52x	Market cap / revenue.
P/B	2.17x	Market cap / shareholders' equity. Only when equity is positive.
P/OCF	10.2x	Market cap / cash from operations, when positive.
EV/Sales	2.09x	Enterprise value / revenue.
EV/EBIT	14.9x	Enterprise value / operating income, when both are positive.
EV/EBITDA	9.96x	Enterprise value / EBITDA, when both are positive.
Earnings yield	5.1%	Net income / market cap (the inverse of P/E).
Dividend yield	1.5%	Dividends paid over the period / market cap.
Shareholder yield	1.5%	(Dividends paid + share buybacks) / market cap.

What was Crane NXT, Co.'s revenue in fiscal 2025?

Crane NXT, Co. reported revenue of $1.66B for fiscal 2025, 11.4% higher than the year before.

Was Crane NXT, Co. profitable in fiscal 2025?

Yes. Net income was $145.1M, a net margin of 8.8%.

How much free cash flow did Crane NXT, Co. generate in fiscal 2025?

Cash from operations of $241.5M minus capital expenditures of $43.2M left free cash flow of $198.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Crane NXT, Co.